Lv1
40 积分 2024-06-26 加入
[Progress in diagnosis and treatment of neuroendocrine carcinoma of cervix]
2天前
已完结
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
6个月前
已完结
Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)
6个月前
已完结
皖公网安备34019202002308
